Imlifidase Shows Promise for the Most Disadvantaged Sensitized Transplant Candidates

Carrie A. Schinstock

doi:10.1097/TP.0000000000003497

Imlifidase Shows Promise for the Most Disadvantaged Sensitized Transplant Candidates

Nephrology and Hypertension

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1660-1661
Number of pages	2
Journal	Transplantation
Volume	105
Issue number	8
DOIs	https://doi.org/10.1097/TP.0000000000003497
State	Published - Aug 1 2021

ASJC Scopus subject areas

Transplantation

Access to Document

10.1097/TP.0000000000003497

Cite this

@article{61616c28f8dd4597b94e960dce96911d,

title = "Imlifidase Shows Promise for the Most Disadvantaged Sensitized Transplant Candidates",

author = "Schinstock, {Carrie A.}",

year = "2021",

month = aug,

day = "1",

doi = "10.1097/TP.0000000000003497",

language = "English (US)",

volume = "105",

pages = "1660--1661",

journal = "Transplantation",

issn = "0041-1337",

publisher = "Lippincott Williams and Wilkins",

number = "8",

}

TY - JOUR

T1 - Imlifidase Shows Promise for the Most Disadvantaged Sensitized Transplant Candidates

AU - Schinstock, Carrie A.

PY - 2021/8/1

Y1 - 2021/8/1

UR - http://www.scopus.com/inward/record.url?scp=85110377520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85110377520&partnerID=8YFLogxK

U2 - 10.1097/TP.0000000000003497

DO - 10.1097/TP.0000000000003497

M3 - Comment/debate

C2 - 33093402

AN - SCOPUS:85110377520

SN - 0041-1337

VL - 105

SP - 1660

EP - 1661

JO - Transplantation

JF - Transplantation

IS - 8

ER -

Imlifidase Shows Promise for the Most Disadvantaged Sensitized Transplant Candidates

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this